Population screening for smoldering multiple myeloma reveals high prevalence
- PMID: 36755165
- DOI: 10.1038/s41591-022-02187-2
Population screening for smoldering multiple myeloma reveals high prevalence
Comment on
-
Prevalence of smoldering multiple myeloma based on nationwide screening.Nat Med. 2023 Feb;29(2):467-472. doi: 10.1038/s41591-022-02183-6. Epub 2023 Feb 6. Nat Med. 2023. PMID: 36747117 Free PMC article.
References
-
- Cowan, A. J. et al. Global burden of multiple myeloma: a systematic analysis for the Global Burden of Disease Study 2016. JAMA Oncol. 4, 1221–1227 (2018). A paper that describes the global burden of multiple myeloma.
-
- Rajkumar, S. V. et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 15, 538–548 (2014). A paper that outlines the diagnostic criteria for multiple myeloma and its precursors. - DOI
-
- Rajkumar, S. V. et al. Smoldering multiple myeloma current treatment algorithms. Blood Cancer J. 12, 129 (2022). A review article that presents arguments in support of the treatment of SMM.
-
- Rögnvaldsson, S. et al. Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies. Blood Cancer J. 11, 94 (2021). An article that describes the design of the iStopMM study in detail.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical